Synthaverse Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Mieczyslaw Starkowicz
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.3yrs |
| CEO ownership | 0.2% |
| Management average tenure | no data |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
CEO
Mieczyslaw Starkowicz
2.3yrs
Tenure
Mr. Mieczyslaw Starkowicz serves as President of the Management Board and Chief Executive Officer at Synthaverse S.A. (formerly known as BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A.) since August 202...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Secretary of Supervisory Board & Member of Supervisory Board | no data | zł24.00k | 6.48% € 4.6m | |
| Member of the Supervisory Board | no data | zł42.00k | 0.072% € 50.9k | |
| Vice Chairman of the Supervisory Board | no data | zł40.00k | 7.2% € 5.1m | |
| Member of Supervisory Board | 16.8yrs | zł39.00k | 0.31% € 215.8k | |
| Member of Supervisory Board | 1.8yrs | no data | no data | |
| Chairman of the Supervisory Board | no data | zł113.00k | 2% € 1.4m | |
| Member of the Supervisory Board | 4.8yrs | zł37.00k | no data | |
| Member of Supervisory Board | 1.8yrs | no data | 0.14% € 100.8k |
3.3yrs
Average Tenure
Experienced Board: 6NQ's board of directors are considered experienced (3.3 years average tenure).